Chiral analysis of methadone and its main metabolite, EDDP, in postmortem brain and blood by automated SPE and liquid chromatography-mass spectrometry

Journal of Analytical Toxicology

Volumn 36, Issue 7, 2012, Pages 487-496

  Holm, Karen Marie Dollerup ^a   Linnet, Kristian ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; METHADONE; OROSOMUCOID; S 2 ETHYL 1,5 DIMETHYL 3,3 DIPHENYLPYRROLINIUM; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; BLOOD; BLOOD SAMPLING; BRAIN TISSUE; CHIRALITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ISOLATION; ELECTROSPRAY; ENANTIOMER; HUMAN; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROCESS OPTIMIZATION; ROBOTICS; SOLID PHASE EXTRACTION;

EID: 84871097536     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/jat/bks057     Document Type: Article

References (42)

1. Pedersen, C.L., Steentoft, A., Kringsholm, B. (2008) Deaths among drug addicts in Eastern Denmark 2005. Ugeskr Laeger, 170, 4124-4127.
2. Ishoy, T., Iversen, C. (2003) Substitutions therapy of opiate addiction in Denmark. Ugeskr Laeger, 165, 3620-3623.
3. Andrews, C.M., Krantz, M.J., Wedam, E.F., Marcuson, M.J., Capacchione, J.F., Haigney, M.C. (2009) Methadone-induced mortality in the treatment of chronic pain: Role of QT prolongation. Cardiology Journal, 16, 210-217.
4. Kristensen, K., Christensen, C.B., Christrup, L.L. (1995) The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Science, 56, L45-L50.
5. Eap, C.B., Buclin, T., Baumann, P. (2002) Interindividual variability of the clinical pharmacokinetics of methadone: Implications for the treatment of opioid dependence. Clinical Pharmacokinetics, 41, 1153-1193.
6. Eap, C.B., Bourquin, M., Martin, J., Spagnoli, J., Livoti, S., Powell, K. et al.; (2000) Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment. Drug and Alcohol Dependence, 61, 47-54.
7. de Vos, J.W., Geerlings, P.J., van den Brink, W., Ufkes, J.G., van Wilgenburg, H. (1995) Pharmacokinetics of methadone and its primary metabolite in 20 opiate addicts. European Journal of Clinical Pharmacology, 48, 361-366.
8. Karch, S.B., Stephens, B.G. (2000) Toxicology and pathology of deaths related to methadone: Retrospective review. Western Journal of Medicine, 172, 11-14.
9. Foster, D.J., Somogyi, A.A., Dyer, K.R., White, J.M., Bochner, F. (2000) Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients. British Journal of Clinical Pharmacology, 50, 427-440.
10. Rodriguez-Rosas, M.E., Medrano, J.G., Epstein, D.H., Moolchan, E.T., Preston, K.L., Wainer, I.W. (2005) Determination of total and free concentrations of the enantiomers of methadone and its metabolite(2-ethylidene-1,5-dimethyl-3,3-diphenyl-pyrrolidine) in human plasma by enantioselective liquid chromatography with mass spectrometric detection. Journal of Chromatography A, 1073, 237-248.
11. Ansermot, N., Rudaz, S., Brawand-Amey, M., Fleury-Souverain, S., Veuthey, J.L., Eap, C.B. (2009) Validation and long-term evaluation of a modified on-line chiral analytical method for therapeutic drug monitoring of (R,S)-methadone in clinical samples. Journal of Chromatography B, 877, 2301-2307.
12. Etter, M.L., George, S., Graybiel, K., Eichhorst, J., Lehotay, D.C. (2005) Determination of free and protein-bound methadone and its major metabolite EDDP: Enantiomeric separation and quantitation by LC/MS/MS. Clinical Biochemistry, 38, 1095-1102.
13. Moody, D.E., Lin, S.N., Chang, Y., Lamm, L., Greenwald, M.K., Ahmed, M.S. (2008) An enantiomer-selective liquid chromatography-tandem mass spectrometry method for methadone and EDDP validated for use in human plasma, urine, and liver microsomes. Journal of Analytical Toxicology, 32, 208-219.
14. Liang, H.R., Foltz, R.L., Meng, M., Bennett, P. (2004) Method development and validation for quantitative determination of methadone enantiomers in human plasma by liquid chromatography/tandem mass spectrometry. Journal of Chromatography B, 806, 191-198.
15. Boulton, D.W., DeVane, C.L. (2000) Development and application of a chiral high performance liquid chromatography assay for pharmacokinetic studies of methadone. Chirality, 12, 681-687.
16. Kelly, T., Doble, P., Dawson, M. (2005) Chiral analysis of methadone and its major metabolites (EDDP and EMDP) by liquid chromatography-mass spectrometry. Journal of Chromatography B, 814, 315-323.
17. Wang, S.C., Ho, I.K., Wu, S.L., Liu, S.C., Kuo, H.W., Lin, K.M. et al. (2010) Development of a method to measure methadone enantiomers and its metabolites without enantiomer standard compounds for the plasma of methadone maintenance patients. Biomedical Chromatography, 24, 782-788.
18. Schappler, J., Guillarme, D., Prat, J., Veuthey, J.L., Rudaz, S. (2008) Validation of chiral capillary electrophoresis-electrospray ionization-mass spectrometry methods for ecstasy and methadone in plasma. Electrophoresis, 29, 2193-2202.
19. Valentova, J., Horakova, R., Pechova, I., Okruhlica, L., Devinsky, F. (2006) Stereoselective determination of methadone and its main metabolite in serum and urine from methadone maintenance patients. Neurology and Endocrinology Letters, 27, 130-133.
20. Foster, D.J., Morton, E.B., Heinkele, G., Murdter, T.E., Somogyi, A.A. (2006) Stereoselective quantification of methadone and a d(6)-labeled isotopomer using high performance liquid chromatography-atmospheric pressure chemical ionization massspectrometry: Application to a pharmacokinetic study in a methadone maintained subject. Therapeutic Drug Monitoring, 28, 559-567.
21. Rudaz, S., Ortelli, D., Gex-Fabry, M., Deglon, J.J., Balant, L., Veuthey, J.L. (1999) Development of validated stereoselective methods for methadone determination in clinical samples. Chirality, 11, 487-494.
22. Angelo, H.R., Beck, N., Kristensen, K. (1999) Enantioselective highperformance liquid chromatographic method for the determination of methadone and its main metabolite in urine using an AGP and a C8 column coupled serially. Journal of Chromatography B, 724, 35-40.
23. Pham-Huy, C., Chikhi-Chorfi, N., Galons, H., Sadeg, N., Laqueille, X., Aymard, N. et al. (1997) Enantioselective high-performance liquid chromatography determination of methadone enantiomers and its major metabolite in human biological fluids using a new derivatized cyclodextrin-bonded phase. Journal of Chromatography B, 700, 155-163.
24. Wang, J.S., Ruan, Y., Taylor, R.M., Donovan, J.L., Markowitz, J.S., DeVane, C.L. (2004) Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice. Psychopharmacology (Berlin), 173, 132-138.
25. Choo, R.E., Jansson, L.M., Scheidweiler, K., Huestis, M.A. (2007) A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometric method for the quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), and 2-Ethyl-5-methyl-3,3-diphenylpyroline (EMDP) in human breast milk. Journal of Analytical Toxicology, 31, 265-269.
26. Gosselin, M., Ramirez Fernandez, M.M., Wille, S.M., Samyn, N., De, B.G., Bourel, B. (2010) Quantification of methadone and its metabolite 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine in third instar larvae of Lucilia sericata (Diptera: Calliphoridae) using liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology, 34, 374-380.
27. Scheurer, J., Moore, C.M. (1992) Solid-phase extraction of drugs from biological tissues-A review. Journal of Analytical Toxicology, 16, 264-269.
28. Stimpfl, T., Vycudilik, W. (2004) Automatic screening in postmortem toxicology. Forensic Science International, 142, 115-125.
29. Johansen, S.S., Linnet, K. (2008) Chiral analysis of methadone and its main metabolite EDDP in postmortem blood by liquid chromatography-mass spectrometry. Journal of Analytical Toxicology, 32, 499-504.
30. Andersen, D., Rasmussen, B.S., Linnet, K. Validation of a fully automated robotic setup for preparation of whole blood samples for LC-MS toxicology analysis. Journal of Analytical Toxicology, 36, 280-287.
31. Little, J.L., Wempe, M.F., Buchanan, C.M. (2006) Liquid chromatography-mass spectrometry/mass spectrometry method development for drug metabolism studies: Examining lipid matrixionization effects in plasma. Journal of Chromatography B, 833, 219-230.
32. Peters, F.T., Drummer, O.H., Musshoff, F. (2007) Validation of new methods. Forensic Science International, 165, 216-224.
33. Bjork, M.K., Nielsen, M.K., Markussen, L.O., Klinke, H.B., Linnet, K. (2010) Determination of 19 drugs of abuse and metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry, 396, 2393-2401.
34. Stimpfl, T., Jurenitsch, J., Vycudilik, W. (2001) General unknown screening in postmortem tissue and blood samples: A semiautomatic solid-phase extraction using polystyrene resins followed by liquid-liquid extraction. Journal of Analytical Toxicology, 25, 125-129.
35. Gunnar, T., Eskola, T., Lillsunde, P. (2006) Fast gas chromatography/mass spectrometric assay for the validated quantitative determination of methadone and the primary metabolite EDDP in whole blood. Rapid Communications in Mass Spectrometry, 20, 673-679.
36. Lowe, R.H., Barnes, A.J., Lehrmann, E., Freed, W.J., Kleinman, J.E., Hyde, T.M. et al. (2006) A validated positive chemical ionization GC/MS method for the identification and quantification of amphetamine, opiates, cocaine, and metabolites in human postmortem brain. Journal of Mass Spectrometry, 41, 175-184.
37. Geier, A., Bergemann, D., von Meyer, L. (1996) Evaluation of a solidphase extraction procedure for the simultaneous determination of morphine, 6-monoacetylmorphine, codeine and dihydrocodeine in plasma and whole blood by GC/MS. International Journal of Legal Medicine, 109, 80-83.
38. Bones, J., Thomas, K.V., Paull, B. (2007) Using environmental analytical data to estimate levels of community consumption of illicit drugs and abused pharmaceuticals. Journal of Environmental Monitoring Supplementary Information, 9, 701-707.
39. Liu, S.J., Roerig, D.L., Wang, R.I. (1983) Brain and plasma levels of methadone and their relationships to analgesic activity of methadone in rats. Drug Metabolism and Disposition, 11, 335-338.
40. Norheim, G. (1973) Methadone in autopsy cases. Z. Rechtsmed, 73, 219-224.
41. Manning, T., Bidanset, J.H., Cohen, S., Lukash, L. (1976) Evaluation of the Abuscreen for methadone. Journal of Forensic Sciences, 21, 112-120.
42. Robinson, A.E., Williams, F.M. (1971) The distribution of methadone in man. Journal of Pharmacy and Pharmacology, 23, 353-358.